长非编码RNA的互动组:转录组表达模式和塑造癌细胞表现型
Nicole R DeSouza1, Danielle Quaranto1, Michelle Carnazza1
1Department of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.
International journal of molecular sciences
|June 28, 2023
概括
长非编码RNAs (lncRNAs) 在癌症的发展和进展中至关重要. 异常的lncRNA表达驱动细胞转化,为癌症诊断和治疗提供了新的点.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- RNA生物学已经显著进步,揭示了新的转录组元素和功能.
- 癌症的发展涉及突变和基因组不稳定性,但差异性基因表达也推动了癌症发生.
- 非编码RNAs,特别是长非编码RNAs (lncRNAs),为癌症中的基因组和表观基因组调节提供了新的见解.
研究的目的:
- 探索不同基因表达模式在癌症突变之外的作用.
- 研究长非编码RNAs (lncRNAs) 在细胞活动和病理转变中的功能.
- 突出 lncRNA 分类,结构,功能和癌症研究中的治疗潜力的重要性.
主要方法:
- 在野生类型的位置中分析差异性基因表达模式.
- 研究基因组和表观基因组调节中的非编码RNA作用.
- 长非编码RNA (lncRNA) 表达的特征及其与细胞活动的相关性.
主要成果:
- 野生类型基因位置中的不同基因表达模式有助于理解癌症机制.
- 异常长非编码RNA (lncRNA) 表达与病态细胞转化相关.
- lncRNA互动原子分析有助于定义癌细胞表型的转录组签名.
结论:
- 长非编码RNAs (lncRNAs) 在控制细胞活动和驱动癌症进展方面发挥着关键作用.
- 了解lncRNA生物学,包括它们的分类,结构和功能,对于癌症研究和分子向至关重要.
- lncRNA互动原子研究增强了癌症特异性转录基因特征的定义,用于治疗开发.
相关概念视频
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Types of RNA
5.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.9K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K


